Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TriQarr: QT Dynamics in Long QT Syndrome
NCT03291145Completed
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Jun 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of spironolactone and carvedilol in long QT syndrome (LQTS), sponsored by Herlev & Gentofte Hospital. Primary endpoint: Corrected QT Interval at 7 days. Started Jun 2017; status: completed.
02
Drugs
spironolactonecarvedilol
03
Conditions
long QT syndrome (LQTS)
Beyond the preview
Go deeper on NCT03291145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291145.